PreprintLicence not statedChemRxiv
Predicting Regulator-Listed N-Nitrosamines from API Structure: A Rule-Based Method with a Retrospectively Corrected FDA and EMA Evaluation
- 1Independent Researcher
Related
- A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal Mitoxantrone Disposition: Preclinical Validation in Rats and Human Extrapolation with Clinical Evaluation.
- Crystal structure, Hirshfeld surface analysis, computational study, molecular docking predictions and biological evaluation of a new Schiff base (E)-2-((2,4-dichlorobenzylidene)amino)aniline
- Reliability of AI Methods in Drug Discovery: Evaluation of Boltz-2 for Structure and Binding Affinity Prediction
- Benzoxazole–benzamide hybrids: synthesis, structure–activity relationships, and multi-biological evaluation
- Performance Evaluation of In Situ Prepolymerized TPU/SMC Composite-Modified Asphalt Mixtures with Aggregate Structure Optimization
BibTeX
@misc{kotian2026predicting,
title = {{Predicting Regulator-Listed N-Nitrosamines from API Structure: A Rule-Based Method with a Retrospectively Corrected FDA and EMA Evaluation}},
author = {Prashant D. Kotian},
howpublished = {ChemRxiv},
year = {2026},
month = oct,
doi = {10.26434/chemrxiv.15011298/v1},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011298/v1},
}
RIS
TY - UNPB
TI - Predicting Regulator-Listed N-Nitrosamines from API Structure: A Rule-Based Method with a Retrospectively Corrected FDA and EMA Evaluation
AU - Prashant D. Kotian
PY - 2026
DA - 2026/10/29
PB - ChemRxiv
DO - 10.26434/chemrxiv.15011298/v1
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011298/v1
ER -